A 5′UTR-Spliced mRNA Isoform Is Specialized for Enhanced HIV-2 gag Translation

Journal of Molecular Biology

Volumn 391, Issue 2, 2009, Pages 426-437

  Strong, Christy L ^a   Lanchy, Jean Marc ^a   Dieng Sarr, Abdoulaye ^b   Kanki, Phyllis J ^b   Lodmell, J Stephen ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

5 UTR; C box; HIV 2; splicing; translation

Indexed keywords

GAG PROTEIN; GENOMIC RNA; ISOPROTEIN; MESSENGER RNA; PYRIMIDINE; LUCIFERASE; VIRUS RNA;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DIMERIZATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; INTRON; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; RETICULOCYTE; RNA SPLICING; RNA TRANSLATION; TRANSLATION REGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL STRAIN COS1; CERCOPITHECUS; GENETICS; METABOLISM; MUTATION; PEPTIDE SYNTHESIS; TUMOR CELL LINE;

HUMAN IMMUNODEFICIENCY VIRUS 2;

5' UNTRANSLATED REGIONS; ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-2; HUMANS; LUCIFERASES; MUTATION; PEPTIDE BIOSYNTHESIS; RNA SPLICING; RNA, VIRAL;

EID: 67650702583     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.06.046     Document Type: Article

References (44)

1. Berkhout B. Structure and function of the human immunodeficiency virus leader RNA. Prog. Nucleic Acid Res. Mol. Biol. 54 (1996) 1-34
2. SenGupta D.N., Berkhout B., Gatignol A., Zhou A.M., and Silverman R.H. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 87 (1990) 7492-7496
3. Parkin N.T., Cohen E.A., Darveau A., Rosen C., Haseltine W., and Sonenberg N. Mutational analysis of the 5′ non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. EMBO J. 7 (1988) 2831-2837
4. Emerman M., Guyader M., Montagnier L., Baltimore D., and Muesing M.A. The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J. 6 (1987) 3755-3760
5. Arya S.K., and Gallo R.C. Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements. Proc. Natl Acad. Sci. USA 85 (1988) 9753-9757
6. Pachulska-Wieczorek K., Purzycka K.J., and Adamiak R.W. New, extended hairpin form of the TAR-2 RNA domain points to the structural polymorphism at the 5′ end of the HIV-2 leader RNA. Nucleic Acids Res. 34 (2006) 2984-2997
7. Chatterjee P., Garzino-Demo A., Swinney P., and Arya S.K. Human immunodeficiency virus type 2 multiply spliced transcripts. AIDS Res. Hum. Retroviruses 9 (1993) 331-335
8. MacNeil A., Sankale J.L., Meloni S.T., Sarr A.D., Mboup S., and Kanki P. Long-term intrapatient viral evolution during HIV-2 infection. J. Infect. Dis. 195 (2007) 726-733
9. Viglianti G.A., Sharma P.L., and Mullins J.I. Simian immunodeficiency virus displays complex patterns of RNA splicing. J. Virol. 64 (1990) 4207-4216
10. Viglianti G.A., Rubinstein E.P., and Graves K.L. Role of TAR RNA splicing in translational regulation of simian immunodeficiency virus from rhesus macaques. J. Virol. 66 (1992) 4824-4833
11. Dirac A.M., Huthoff H., Kjems J., and Berkhout B. Regulated HIV-2 RNA dimerization by means of alternative RNA conformations. Nucleic Acids Res. 30 (2002) 2647-2655
12. Lanchy J.M., Rentz C.A., Ivanovitch J.D., and Lodmell J.S. Elements located upstream and downstream of the major splice donor site influence the ability of HIV-2 leader RNA to dimerize in vitro. Biochemistry 42 (2003) 2634-2642
13. MacNeil A., Sarr A.D., Sankale J.L., Meloni S.T., Mboup S., and Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. J. Virol. 81 (2007) 5325-5330
14. Lanchy J.M., Szafran Q.N., and Lodmell J.S. Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro. Nucleic Acids Res. 32 (2004) 4585-4595
15. Griffin S.D., Allen J.F., and Lever A.M. The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity. J. Virol. 75 (2001) 12058-12069
16. Pesole G., Mignone F., Gissi C., Grillo G., Licciulli F., and Liuni S. Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276 (2001) 73-81
17. Hong X., Scofield D.G., and Lynch M. Intron size, abundance, and distribution within untranslated regions of genes. Mol. Biol. Evol. 23 (2006) 2392-2404
18. Charron M., Shaper J.H., and Shaper N.L. The increased level of beta1,4-galactosyltransferase required for lactose biosynthesis is achieved in part by translational control. Proc. Natl Acad. Sci. USA 95 (1998) 14805-14810
19. Pickering B.M., and Willis A.E. The implications of structured 5′ untranslated regions on translation and disease. Semin. Cell Dev. Biol. 16 (2005) 39-47
20. Hughes T.A. Regulation of gene expression by alternative untranslated regions. Trends Genet. 22 (2006) 119-122
21. Merrick W.C. Cap-dependent and cap-independent translation in eukaryotic systems. Gene 332 (2004) 1-11
22. Purcell D.F., and Martin M.A. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J. Virol. 67 (1993) 6365-6378
23. Babendure J.R., Babendure J.L., Ding J.H., and Tsien R.Y. Control of mammalian translation by mRNA structure near caps. RNA 12 (2006) 851-861
24. Geballe A.P., and Gray M.K. Variable inhibition of cell-free translation by HIV-1 transcript leader sequences. Nucleic Acids Res. 20 (1992) 4291-4297
25. Bannwarth S., and Gatignol A. HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. Curr. HIV Res. 3 (2005) 61-71
26. Yilmaz A., Bolinger C., and Boris-Lawrie K. Retrovirus translation initiation: issues and hypotheses derived from study of HIV-1. Curr. HIV Res. 4 (2006) 131-139
27. Lanchy J.M., Ivanovitch J.D., and Lodmell J.S. A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA. RNA 9 (2003) 1007-1018
28. Baig T.T., Strong C.L., Lodmell J.S., and Lanchy J.M. Regulation of primate lentiviral RNA dimerization by structural entrapment. Retrovirology 5 (2008) 65
29. Abbink T.E., and Berkhout B. A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J. Biol. Chem. 278 (2003) 11601-11611
30. Song R., Kafaie J., and Laughrea M. Role of the 5′ TAR stem-loop and the U5-AUG duplex in dimerization of HIV-1 genomic RNA. Biochemistry 47 (2008) 3283-3293
31. Abbink T.E., Ooms M., Haasnoot P.C., and Berkhout B. The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation. Biochemistry 44 (2005) 9058-9066
32. Frendewey D., and Keller W. Stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences. Cell 42 (1985) 355-367
33. Ruskin B., and Green M.R. Role of the 3′ splice site consensus sequence in mammalian pre-mRNA splicing. Nature 317 (1985) 732-734
34. Green M.R. Pre-mRNA splicing. Annu. Rev. Genet. 20 (1986) 671-708
35. Herbreteau C.H., Weill L., Decimo D., Prevot D., Darlix J.L., Sargueil B., and Ohlmann T. HIV-2 genomic RNA contains a novel type of IRES located downstream of its initiation codon. Nat. Struct. Mol. Biol. 12 (2005) 1001-1007
36. Ricci E.P., Herbreteau C.H., Decimo D., Schaupp A., Datta S.A., Rein A., Darlix J.L., et al. In vitro expression of the HIV-2 genomic RNA is controlled by three distinct internal ribosome entry segments that are regulated by the HIV protease and the Gag polyprotein. RNA 14 (2008) 1443-1455
37. Butsch M., and Boris-Lawrie K. Destiny of unspliced retroviral RNA: ribosome and/or virion?. J. Virol. 76 (2002) 3089-3094
38. Anderson E.C., and Lever A.M. Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J. Virol. 80 (2006) 10478-10486
39. Guyader M., Emerman M., Sonigo P., Clavel F., Montagnier L., and Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326 (1987) 662-669
40. Ryan-Graham M.A., and Peden K.W. Both virus and host components are important for the manifestation of a Nef-phenotype in HIV-1 and HIV-2. Virology 213 (1995) 158-168
41. McCann E.M., and Lever A.M. Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J. Virol. 71 (1997) 4133-4137
42. Kaye J.F., and Lever A.M. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J. Virol. 72 (1998) 5877-5885
43. Salahuddin S.Z., Markham P.D., Wong-Staal F., Franchini G., Kalyanaraman V.S., and Gallo R.C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129 (1983) 51-64
44. Kanki P., M'Boup S., Marlink R., Travers K., Hsieh C.C., Gueye A., et al. Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in West African female prostitutes. Am. J. Epidemiol. 136 (1992) 895-907